As part of CME America’s commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some infusion sets do not meet the ±5% delivery accuracy for the

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cme-america-announces-follow-voluntary-recall-bodyguardr-infusion-system-administration-sets